Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition of Melt Pharmaceuticals, Inc. (Melt), a ...

The Plastic and Polymer segment leads with a 45.2% share in 2025 and is projected to expand at a 15.3% CAGR through 2035. Bio ...